End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.77 CNY | -0.04% | -0.74% | -9.03% |
Apr. 18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Apr. 17 | Fosun Pharma Unit’s New Drug Application for CMV, HSV Drug Accepted by Chinese Regulator | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.03% | 7.48B | |
+27.97% | 672B | |
+23.25% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+1.66% | 211B | |
-0.75% | 203B | |
-10.47% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Market Chatter: Fosun Pharma to Kick Off Production of BioNTech Vaccines in August; Shares Slump 7%